| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Urology, Yokohama City University School of Medicine, 3-46 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232, Japan
We have analyzed the expression of 12 protooncogenes, c-Ha-ras, c-Ki-ras, N-ras, c-myc, N-myc, c-fos, c-abl, c-fes, c-fms, c-raf, c-erbB-1, and c-erbB-2, in tissues of human renal cell carcinomas and in adjacent normal kidneys. Comparative densitometry of Northern blot analyses demonstrated enhanced level of c-myc gene expression, i.e., greater than threefold increase over normal kidney tissues, in 11 of 15 (73%) of the tumors examined. Increased levels of c-erbB-1 mRNA were likewise observed in seven of 15 (47%). Interestingly, many of the tumors exhibiting elevated levels of c-erbB-1 revealed increases in c-myc mRNA levels. However, Southern blot analysis failed to detect gene amplification or rearrangement in the tumors with elevated levels of c-myc and/or c-erbB-1. Although N-ras, c-fos, and c-raf gene transcripts were detected in both malignant and normal tissues, differences in these protooncogene expressions were not found between the carcinomas and normal kidneys. Significant elevations of expression were found in one of 16 cases of each for c-Ha-ras and c-fms, whereas expression of c-Ki-ras, N-myc, c-fes, c-abl, or c-erbB-2 could not be detected in any of the tissues surveyed. These results suggested that activation of c-myc and c-erbB-1 genes may be involved in the development of human renal cell carcinomas.
1 This work is supported by Grant-in-Aid (Grants 61570711 and 62771199) from the Ministry of Education, Science and Culture of Japan.
2 To whom requests for reprints should be addressed.
Received 7/ 7/87. Revised 8/ 8/88. Accepted 9/ 2/88.
This article has been cited by other articles:
![]() |
H. Sultmann, A. v. Heydebreck, W. Huber, R. Kuner, A. Buness, M. Vogt, B. Gunawan, M. Vingron, L. Fuzesi, and A. Poustka Gene Expression in Kidney Cancer Is Associated with Cytogenetic Abnormalities, Metastasis Formation, and Patient Survival Clin. Cancer Res., January 15, 2005; 11(2): 646 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Dawson, C. Guo, R. Zak, B. Dorsey, J. Smoot, J. Wong, and A. Hussain A Phase II Trial of Gefitinib (Iressa, ZD1839) in Stage IV and Recurrent Renal Cell Carcinoma Clin. Cancer Res., December 1, 2004; 10(23): 7812 - 7819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Rowinsky, G. H. Schwartz, J. A. Gollob, J. A. Thompson, N. J. Vogelzang, R. Figlin, R. Bukowski, N. Haas, P. Lockbaum, Y.-P. Li, et al. Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer J. Clin. Oncol., August 1, 2004; 22(15): 3003 - 3015. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Moch, P. Schraml, L. Bubendorf, M. Mirlacher, J. Kononen, T. Gasser, M. J. Mihatsch, O. P. Kallioniemi, and G. Sauter High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma Am. J. Pathol., April 1, 1999; 154(4): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Motzer, N. H. Bander, and D. M. Nanus Renal-Cell Carcinoma N. Engl. J. Med., September 19, 1996; 335(12): 865 - 875. [Full Text] [PDF] |
||||
![]() |
J. M. Boer, W. K. Huber, H. Sultmann, F. Wilmer, A. von Heydebreck, S. Haas, B. Korn, B. Gunawan, A. Vente, L. Fuzesi, et al. Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31,500-Element cDNA Array Genome Res., November 1, 2001; 11(11): 1861 - 1870. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |